China Resources Medical Holdings Company Limited (1PH) — Capital Reinvestment Ratio
China Resources Medical Holdings Company Limited (1PH) has a Capital Reinvestment Ratio of 0.36x as of June 2023, meaning it reinvests 0% of its operating cash flow (€270.22 Million) in capital expenditures (€96.85 Million). Check tangible net worth ratio of China Resources Medical Holdings Company to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China Resources Medical Holdings Company Limited Capital Reinvestment Ratio (2016–2025)
This chart tracks China Resources Medical Holdings Company Limited's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see China Resources Medical Holdings Company operating cash flow efficiency.
Annual Capital Reinvestment Ratio for China Resources Medical Holdings Company Limited (2016–2025)
Year-by-year Capital Reinvestment Ratio for China Resources Medical Holdings Company Limited from 2016 to 2025. See China Resources Medical Holdings Company free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | €1.36 Billion | €514.13 Million | ▼ -14.7% |
| 2024 | 0.44x | €1.27 Billion | €563.69 Million | ▲ +9.0% |
| 2023 | 0.41x | €1.20 Billion | €486.68 Million | ▲ +0.9% |
| 2022 | 0.40x | €626.58 Million | €252.87 Million | ▲ +44.5% |
| 2021 | 0.28x | €710.43 Million | €198.43 Million | ▼ -14.2% |
| 2020 | 0.33x | €643.69 Million | €209.55 Million | ▲ +227.7% |
| 2019 | 0.10x | €366.05 Million | €36.37 Million | ▼ -42.4% |
| 2018 | 0.17x | €334.15 Million | €57.61 Million | ▲ +129.6% |
| 2017 | 0.08x | €459.54 Million | €34.50 Million | ▼ -60.4% |
| 2016 | 0.19x | €223.79 Million | €42.45 Million | — |